Zurich Cantonal Bank Portfolio holdings
AUM
$40.9B
1-Year Return
22.88%
This Quarter Return
+14.1%
1 Year Return
+22.88%
3 Year Return
+106.76%
5 Year Return
+189.8%
10 Year Return
+428.78%
AUM
$40.9B
AUM Growth
+$6.08B
(+17%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
5.69%
Top 10 Holdings %
Top 10 Hldgs %
33.91%
Holding
2,675
New
37
Increased
1,264
Reduced
635
Closed
96
Top Buys
| 1 |
AMRZ
Amrize Ltd
AMRZ
|
$452M |
| 2 |
NVIDIA
NVDA
|
$177M |
| 3 |
Apple
AAPL
|
$170M |
| 4 |
Microsoft
MSFT
|
$170M |
| 5 |
UBS Group
UBS
|
$134M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$112M |
| 2 |
CME Group
CME
|
$93.4M |
| 3 |
Procter & Gamble
PG
|
$65.5M |
| 4 |
Walt Disney
DIS
|
$60.1M |
| 5 |
Verizon
VZ
|
$53.2M |
Sector Composition
| 1 | Technology | 31.19% |
| 2 | Financials | 17.34% |
| 3 | Healthcare | 10.5% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Industrials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
2451
Centessa Pharmaceuticals
CNTA
$2.11B
| $8.96K | ﹤0.01% |
682
-73
| -10% | -$959 |
|
2452
Mercer International
MERC
$216M
| $8.92K | ﹤0.01% |
2,549
| – | – |
|
2453
ArriVent BioPharma
AVBP
$819M
| $8.9K | ﹤0.01% |
409
-48
| -11% | -$1.05K |
|
2454
Zegna
ZGN
$2.29B
| $7.97K | ﹤0.01% |
932
| – | – |
|
2455
Alvotech
ALVO
$2.6B
| $7.91K | ﹤0.01% |
867
-160
| -16% | -$1.46K |
|
|
OTLY
2456
Oatly Group
OTLY
$524M
| $7.91K | ﹤0.01% |
666
-7
| -1% | -$83 |
|
2457
Monte Rosa Therapeutics
GLUE
$305M
| $7.04K | ﹤0.01% |
1,560
-293
| -16% | -$1.32K |
|
2458
Praxis Precision Medicines
PRAX
$986M
| $7.02K | ﹤0.01% |
167
| – | – |
|
|
MESO
2459
Mesoblast
MESO
$1.84B
| $6.89K | ﹤0.01% |
633
| – | – |
|
2460
Cartesian Therapeutics
RNAC
$277M
| $6.65K | ﹤0.01% |
640
-72
| -10% | -$748 |
|
2461
Alpha Teknova
TKNO
$233M
| $6.59K | ﹤0.01% |
1,342
-265
| -16% | -$1.3K |
|
2462
Altimmune
ALT
$334M
| $6.24K | ﹤0.01% |
1,612
-14,868
| -90% | -$57.5K |
|
2463
Design Therapeutics
DSGN
$367M
| $6.12K | ﹤0.01% |
1,817
-348
| -16% | -$1.17K |
|
2464
Esperion Therapeutics
ESPR
$540M
| $5.99K | ﹤0.01% |
6,082
| – | – |
|
2465
MaxCyte
MXCT
$150M
| $5.91K | ﹤0.01% |
2,709
-574
| -17% | -$1.25K |
|
|
TECX
2466
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $5.62K | ﹤0.01% |
283
| – | – |
|
2467
Codexis
CDXS
$218M
| $5.55K | ﹤0.01% |
2,276
-2,450
| -52% | -$5.98K |
|
2468
Entrada Therapeutics
TRDA
$201M
| $5.01K | ﹤0.01% |
746
| – | – |
|
2469
Omeros
OMER
$284M
| $4.07K | ﹤0.01% |
1,358
| – | – |
|
2470
Beyond Meat
BYND
$189M
| $3.64K | ﹤0.01% |
1,042
-10,840
| -91% | -$37.8K |
|
2471
FuelCell Energy
FCEL
$92.3M
| $2.66K | ﹤0.01% |
474
-123,203
| -100% | -$691K |
|
2472
Pliant Therapeutics
PLRX
$114M
| $1.01K | ﹤0.01% |
871
-8,123
| -90% | -$9.42K |
|
2473
Editas Medicine
EDIT
$248M
| $792 | ﹤0.01% |
360
-6,192
| -95% | -$13.6K |
|
|
CMRC
2474
Commerce.com, Inc. Series 1 Common Stock
CMRC
$361M
| $770 | ﹤0.01% |
154
-12,819
| -99% | -$64.1K |
|
2475
Pluri
PLUR
$39.5M
| $673 | ﹤0.01% |
136
| – | – |
|